# Mannatech Inc: financial statements, quarterly

MTEX · Nasdaq · CIK 1056358 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mtex.md) · [Financials](/companies/mtex/financials.md) · [Filings](/companies/mtex/filings.md) · [Insiders](/companies/mtex/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mtex/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [32.6](/filings/0001056358-24-000081.md) | [32.7 d](/filings/0001056358-25-000018.md) | [29.4](/filings/0001056358-25-000047.md) | [27.7](/filings/0001056358-24-000063.md) | [31.7](/filings/0001437749-25-034431.md) | [29.0 d](/filings/0001437749-26-012430.md) | [26.6](/filings/0001437749-26-017043.md) | [25.7](/filings/0001437749-26-027304.md) | [29.2](/filings/0001437749-25-034431.md) | [26.6 d](/filings/0001437749-26-012430.md) | [24.9](/filings/0001437749-26-017043.md) | [26.7](/filings/0001437749-26-027304.md) |
| Cost of revenue | $m | [6.6](/filings/0001056358-24-000081.md) | [8.0 d](/filings/0001056358-25-000018.md) | [6.3](/filings/0001056358-25-000047.md) | [6.4](/filings/0001056358-24-000063.md) | [8.1](/filings/0001437749-25-034431.md) | [5.6 d](/filings/0001437749-26-012430.md) | [6.8](/filings/0001437749-26-017043.md) | [6.8](/filings/0001437749-26-027304.md) | [6.9](/filings/0001437749-25-034431.md) | [6.6 d](/filings/0001437749-26-012430.md) | [6.1](/filings/0001437749-26-017043.md) | [6.2](/filings/0001437749-26-027304.md) |
| Gross profit | $m | [25.9](/filings/0001056358-24-000081.md) | [24.6 d](/filings/0001056358-25-000018.md) | [23.1](/filings/0001056358-25-000047.md) | [21.4](/filings/0001056358-24-000063.md) | [23.6](/filings/0001437749-25-034431.md) | [23.4 d](/filings/0001437749-26-012430.md) | [19.7](/filings/0001437749-26-017043.md) | [18.9](/filings/0001437749-26-027304.md) | [22.3](/filings/0001437749-25-034431.md) | [20.1 d](/filings/0001437749-26-012430.md) | [18.9](/filings/0001437749-26-017043.md) | [20.5](/filings/0001437749-26-027304.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | [9.8](/filings/0001437749-25-034431.md) | [10.4 d](/filings/0001437749-26-012430.md) | [10.0](/filings/0001437749-26-017043.md) | [10.8](/filings/0001437749-26-027304.md) | [9.1](/filings/0001437749-25-034431.md) | [9.8 d](/filings/0001437749-26-012430.md) | [9.3](/filings/0001437749-26-017043.md) | [9.0](/filings/0001437749-26-027304.md) |
| Operating income | $m | [0.2](/filings/0001056358-24-000081.md) | [(0.9) d](/filings/0001056358-25-000018.md) | [0.8](/filings/0001056358-25-000047.md) | [(1.1)](/filings/0001056358-24-000063.md) | [0.9](/filings/0001437749-25-034431.md) | [0.9 d](/filings/0001437749-26-012430.md) | [(0.8)](/filings/0001437749-26-017043.md) | [(1.4)](/filings/0001437749-26-027304.md) | [2.0](/filings/0001437749-25-034431.md) | [(0.2) d](/filings/0001437749-26-012430.md) | [(0.2)](/filings/0001437749-26-017043.md) | [1.0](/filings/0001437749-26-027304.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001437749-25-034431.md) | [0.1 d](/filings/0001437749-26-012430.md) | [0.1](/filings/0001437749-26-017043.md) | [0.1](/filings/0001437749-26-027304.md) | [0.1](/filings/0001437749-25-034431.md) | [0.1 d](/filings/0001437749-26-012430.md) | [0.1](/filings/0001437749-26-017043.md) | [0.1](/filings/0001437749-26-027304.md) |
| Income tax | $m | [0.5](/filings/0001056358-24-000081.md) | [(0.1) d](/filings/0001056358-25-000018.md) | [0.5](/filings/0001056358-25-000047.md) | [0.5](/filings/0001056358-24-000063.md) | [(0.4)](/filings/0001437749-25-034431.md) | [0.6 d](/filings/0001437749-26-012430.md) | [0.2](/filings/0001437749-26-017043.md) | [0.0](/filings/0001437749-26-027304.md) | [0.6](/filings/0001437749-25-034431.md) | [11.5 d](/filings/0001437749-26-012430.md) | [0.2](/filings/0001437749-26-017043.md) | [0.2](/filings/0001437749-26-027304.md) |
| Net income | $m | [0.0](/filings/0001056358-24-000081.md) | [(1.8) d](/filings/0001056358-25-000018.md) | [1.2](/filings/0001437749-25-034431.md) | [(0.6)](/filings/0001437749-25-034431.md) | [(0.3)](/filings/0001437749-25-034431.md) | [2.3 d](/filings/0001437749-26-012430.md) | [(1.5)](/filings/0001437749-26-027304.md) | [(4.3)](/filings/0001437749-26-027304.md) | [1.9](/filings/0001437749-25-034431.md) | [(11.3) d](/filings/0001437749-26-012430.md) | [1.0](/filings/0001437749-26-027304.md) | [1.0](/filings/0001437749-26-027304.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001056358-24-000081.md) | not reported | [0.63](/filings/0001056358-25-000047.md) | [(0.33)](/filings/0001056358-24-000063.md) | [(0.17)](/filings/0001437749-25-034431.md) | not reported | [(0.80)](/filings/0001437749-26-017043.md) | [(2.27)](/filings/0001437749-26-027304.md) | [1.01](/filings/0001437749-25-034431.md) | not reported | [0.49](/filings/0001437749-26-017043.md) | [0.53](/filings/0001437749-26-027304.md) |
| Basic EPS | $ per share | [0.01](/filings/0001056358-24-000081.md) | not reported | [0.63](/filings/0001056358-25-000047.md) | [(0.33)](/filings/0001056358-24-000063.md) | [(0.17)](/filings/0001437749-25-034431.md) | not reported | [(0.80)](/filings/0001437749-26-017043.md) | [(2.27)](/filings/0001437749-26-027304.md) | [1.01](/filings/0001437749-25-034431.md) | not reported | [0.49](/filings/0001437749-26-017043.md) | [0.53](/filings/0001437749-26-027304.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.9](/filings/0001056358-24-000081.md) | [7.7](/filings/0001056358-25-000018.md) | [7.9](/filings/0001056358-24-000042.md) | [9.2](/filings/0001056358-24-000063.md) | [12.2](/filings/0001056358-24-000081.md) | [11.4](/filings/0001437749-26-012430.md) | [9.3](/filings/0001056358-25-000047.md) | not reported | [7.1](/filings/0001437749-25-034431.md) | [6.2](/filings/0001437749-26-027304.md) | [7.0](/filings/0001437749-26-017043.md) | [6.0](/filings/0001437749-26-027304.md) |
| Current assets | $m | [28.6](/filings/0001056358-23-000067.md) | [27.7](/filings/0001056358-25-000018.md) | [28.3](/filings/0001056358-24-000042.md) | [27.9](/filings/0001056358-24-000063.md) | [28.7](/filings/0001056358-24-000081.md) | [26.1](/filings/0001437749-26-012430.md) | [26.5](/filings/0001056358-25-000047.md) | not reported | [22.1](/filings/0001437749-25-034431.md) | [20.6](/filings/0001437749-26-027304.md) | [21.2](/filings/0001437749-26-017043.md) | [19.4](/filings/0001437749-26-027304.md) |
| Total assets | $m | [42.2](/filings/0001056358-23-000067.md) | [41.2](/filings/0001056358-25-000018.md) | [41.1](/filings/0001056358-24-000042.md) | [39.9](/filings/0001056358-24-000063.md) | [40.6](/filings/0001056358-24-000081.md) | [36.1](/filings/0001437749-26-012430.md) | [36.7](/filings/0001056358-25-000047.md) | not reported | [33.9](/filings/0001437749-25-034431.md) | [30.0](/filings/0001437749-26-027304.md) | [29.9](/filings/0001437749-26-017043.md) | [27.5](/filings/0001437749-26-027304.md) |
| Current liabilities | $m | [26.3](/filings/0001056358-23-000067.md) | [25.8](/filings/0001056358-25-000018.md) | [26.1](/filings/0001056358-24-000042.md) | [24.0](/filings/0001056358-24-000063.md) | [23.0](/filings/0001056358-24-000081.md) | [20.9](/filings/0001437749-26-012430.md) | [22.6](/filings/0001056358-25-000047.md) | not reported | [19.5](/filings/0001437749-25-034431.md) | [18.7](/filings/0001437749-26-027304.md) | [19.5](/filings/0001437749-26-017043.md) | [16.9](/filings/0001437749-26-027304.md) |
| Total liabilities | $m | [31.5](/filings/0001056358-23-000067.md) | [30.7](/filings/0001056358-25-000018.md) | [30.6](/filings/0001056358-24-000042.md) | [31.7](/filings/0001056358-24-000063.md) | [30.6](/filings/0001056358-24-000081.md) | [27.4](/filings/0001437749-26-012430.md) | [29.1](/filings/0001056358-25-000047.md) | not reported | [27.0](/filings/0001437749-25-034431.md) | [35.2](/filings/0001437749-26-027304.md) | [35.4](/filings/0001437749-26-017043.md) | [32.4](/filings/0001437749-26-027304.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [2.9](/filings/0001437749-25-034431.md) | [2.8](/filings/0001437749-26-012430.md) | [2.8](/filings/0001437749-26-017043.md) | [2.8](/filings/0001437749-26-027304.md) |
| Shareholders' equity | $m | [10.7](/filings/0001056358-24-000081.md) | [10.5](/filings/0001437749-26-012430.md) | [10.4](/filings/0001437749-25-034431.md) | [8.2](/filings/0001437749-25-034431.md) | [10.0](/filings/0001437749-25-034431.md) | [8.6](/filings/0001437749-26-027304.md) | [7.6](/filings/0001437749-26-027304.md) | [6.0](/filings/0001437749-26-027304.md) | [7.0](/filings/0001437749-25-034431.md) | [(5.2)](/filings/0001437749-26-027304.md) | [(5.6)](/filings/0001437749-26-027304.md) | [(5.0)](/filings/0001437749-26-027304.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [287 d](/filings/0001056358-24-000081.md) | [(1,321) d](/filings/0001056358-25-000018.md) | [1,874](/filings/0001056358-25-000047.md) | [(2,666) d](/filings/0001056358-24-000063.md) | [3,272 d](/filings/0001437749-25-034431.md) | [(219) d](/filings/0001437749-26-012430.md) | [(1,368)](/filings/0001437749-26-017043.md) | [(3,718) d](/filings/0001437749-26-027304.md) | [2,412 d](/filings/0001437749-25-034431.md) | [(289) d](/filings/0001437749-26-012430.md) | [1,126](/filings/0001437749-26-017043.md) | [(792) d](/filings/0001437749-26-027304.md) |
| Capital expenditure | $k | [186 d](/filings/0001056358-24-000081.md) | [208 d](/filings/0001056358-25-000018.md) | [61.0](/filings/0001056358-25-000047.md) | [82.0 d](/filings/0001056358-24-000063.md) | [260 d](/filings/0001437749-25-034431.md) | [(106) d](/filings/0001437749-26-012430.md) | [489](/filings/0001437749-26-017043.md) | [142 d](/filings/0001437749-26-027304.md) | [548 d](/filings/0001437749-25-034431.md) | [174 d](/filings/0001437749-26-012430.md) | [129](/filings/0001437749-26-017043.md) | [10.0 d](/filings/0001437749-26-027304.md) |
| Dividends paid | $k | [0.0 d](/filings/0001056358-24-000081.md) | [0.0 d](/filings/0001056358-25-000018.md) | [0.0](/filings/0001056358-24-000042.md) | [0.0 d](/filings/0001056358-24-000063.md) | [0.0 d](/filings/0001056358-24-000081.md) | [0.0 d](/filings/0001056358-25-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | [78.0 d](/filings/0001056358-24-000081.md) | [0.0 d](/filings/0001056358-25-000018.md) | not reported | not reported | [0.0 d](/filings/0001056358-24-000081.md) | [0.0 d](/filings/0001056358-25-000018.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q3 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [1,949](/filings/0001056358-23-000067.md) | [1,891](/filings/0001056358-24-000042.md) | [1,870](/filings/0001056358-24-000063.md) | [1,863](/filings/0001056358-24-000081.md) | [1,884](/filings/0001056358-25-000047.md) | [1,885](/filings/0001056358-24-000063.md) | [1,885](/filings/0001437749-25-034431.md) | [1,901](/filings/0001437749-26-017043.md) | [1,901](/filings/0001437749-26-027304.md) | [1,901](/filings/0001437749-25-034431.md) | [1,931](/filings/0001437749-26-017043.md) | [1,930](/filings/0001437749-26-027304.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,929,670 at 2026-08-05, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027304.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.